Navigation Links
InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet™ (Pirfenidone) in Europe
Date:12/17/2010

n the European headquarters in Basel, Switzerland and has worked in Switzerland, the UK, the US and Italy.  The following executives will report to Mr. Di Nepi.
  • Senior Vice President, EU Medical and Global Medical Advisor – Frank T. Weber, M.D.   Dr. Weber has 20 years of industry experience, having served most recently as Chief Medical Officer at Merck Serono where he played a key role in the registration and reimbursement processes in Europe for Erbitux® (cetuximab).  Dr. Weber previously served in various medical affairs positions at American Cyanamid/Lederle, Sythelabo and Merck KGaA.  He also worked on the national reimbursement side as Medical Director with MedNet, a Munich Re/United Health Care joint venture.  Dr. Weber began his career in healthcare as a surgeon and immunologist.  Dr. Weber has worked in Germany, Switzerland, France, the UK and the United States.  He will be based in the European headquarters in Basel, Switzerland.
  • Senior Vice President and General Manager, Germany – Markus Leyck Dieken, M.D. Dr. Dieken joins InterMune from Novartis, where he was Head of the European Region for the vaccines business and Managing Director of Novartis-Behring's German operations.  Prior to Novartis, he served for 10 years with Novo Nordisk Germany in various roles in Medical Affairs, Marketing and Sales, and then as General Manager of the German subsidiary and Vice President, Central Europe.  He has worked in Germany and Switzerland.  Dr. Leyck Dieken will be based in Berlin, Germany.  
  • Vice President, Sales and Marketing, Europe – Ms. Manuela Maronati.  Ms. Maronati brings 15 years of sales and marketing experience, including the past seven years with Amgen where she served as an International Senior Marketing Manager on the Neupogen® (filgrastim) franchise, and where she previously launched a new medical device f
    '/>"/>

  • SOURCE InterMune, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. InterMune to Release Third Quarter Financial Results on October 28
    2. InterMune Sells Danoprevir Rights to Roche for $175 Million
    3. InterMune to Present at 2010 Citi Health Care Conference
    4. InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone) New Drug Application
    5. InterMune to Release First Quarter Financial Results on April 29
    6. InterMune Announces Submission of MAA for Pirfenidone for the Treatment of Patients With IPF
    7. InterMune Announces Proposed Public Offering of Common Stock
    8. InterMune to Release Third Quarter Financial Results on November 5
    9. InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
    10. InterMune to Present at Canaccord Adams Conference
    11. InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... 2013 was a banner year of ... They saw continued independent research led by the team ... a $1 million grant from the Susanne Marcus Collins ... a peer reviewed journal, Amy Grant highlighted Brainwave Optimization® ...
    (Date:1/14/2014)... January 14, 2014 Carahsoft and CDS ... January 23, 2014 at 2pm EST (11am PST), “Natural ... topic focuses on how technology can turn raw, heterogeneous ... for government agencies. The online webinar will last approximately ...
    (Date:1/14/2014)... The largest international professional organization of scientists ... derivatives thereof has endorsed an educational program that ... challenges of adulterated herb and botanical products. ... The Society for Medicinal Plant and Natural Product ...
    (Date:1/14/2014)... Global Record Systems, LLC, (GRS), a ... for patients, physicians, the biopharmaceutical industry, regulators, payers, ... signing of a three-year Research Collaboration Agreement (RCA) ... This initiative is designed to generate disruptive ...
    Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
    ... focused to spot sizes smaller than half the wavelength ... beat this diffraction limit is based on optical antennas, ... They have the ability to concentrate (focus) light to ... magnitude smaller than what conventional lenses can achieve. Tiny ...
    ... As previously announced on October 24th, 2009 delSECUR CORPORATION ... its del-Id system to QTech Systems Inc. in an Asset ... that time and as mentioned in the Press Release on ... diligently on the del-Id prototype development for commercialization. ...
    ... Cellectis (Alternext: ALCLS), the genome engineering specialist, ... with a pharmaceutical company covering certain uses of its homologous ... field. This agreement has triggered an immediate payment ... of the arrangement have not been disclosed. ...
    Cached Biology Technology:Transmission lines for nanofocusing of infrared light 2Transmission lines for nanofocusing of infrared light 3delSECUR CORPORATION Announces Its Dissolution; and the Distribution of Its Asset to Its Lenders and Shareholders of the Corporation 2
    (Date:4/17/2014)... NY, April 17, 2014The development of stem cell therapies ... ability to characterize stem cell populations based on cell ... discovered a new marker that is highly expressed in ... cord blood, which they describe in an article in ... Mary Ann Liebert, Inc., publishers. The article is available ...
    (Date:4/17/2014)... Down syndrome - or trisomy 21 - is the ... from a chromosomal abnormality where cells of affected individuals ... the human genome). A study conducted by Stylianos Antonarakis ... and Development at the University of Geneva (UNIGE) Faculty ... on how the extra chromosome 21 upsets the equilibrium ...
    (Date:4/17/2014)... White House honored Clemson professor Rajendra Singh Thursday ... to promote and expand solar deployment in the ... D. Houser Banks Professor of Electrical and Computer ... Nanoelectronics, is considered a local hero leading the ... economic opportunity in solar power and driving policy ...
    Breaking Biology News(10 mins):Trisomy 21: How an extra little chromosome throws the entire genome off balance 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 3White House honors Clemson professor as 'Champion of Change' for solar deployment 2
    ... This release is available in German . ... against diseases. The early detection of pathogens and the subsequent ... a protective shield. However, the pathogens that cause plant diseases ... natural cell wall reaction in plants. "One particularly ingenious attacker, ...
    ... are translated into a perception by complex interactions of ... temporal organization of neuronal activity during decision-making and object ... Max Planck Institute for Biological Cybernetics in Tbingen, in ... Institute for Medical Research in Heidelberg, now investigated how ...
    ... WEST LAFAYETTE, Ind. - Purdue University biologists identified a new ... could provide a target for new antibiotics. Zhao-Qing Luo, ... said the team discovered a new enzyme used by the ... - to control its host cell in order to take ...
    Cached Biology News:TUM researchers discover a new switch in resistance to plant diseases 2Deeper insight in the activity of cortical cells 2Deeper insight in the activity of cortical cells 3Purdue biologists identify new strategy used by bacteria during infection 2Purdue biologists identify new strategy used by bacteria during infection 3
    Mouse Wnt-9b Affinity Purified Polyclonal Ab Keywords: Wnt 9b Protein Family: Cancer Stem Cell Markers, Wnt Ligands...
    One-step, microplate or cuvet, colorimetric, linear detection range 0.6 mM to 100 mM. Procedure: 2 min....
    One-step, microplate or cuvet, colorimetric, linear detection range 6 mg/dL to 100mg/dL. Procedure: 15 min....
    assays for phosphatase, lipase, nucleoside triphosphatases (ATPase, GTPase etc). HTS and follow up studies for phosphatase inhibitors. Quantitation of phosphate content in protein, lipids, and DNA....
    Biology Products: